University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Bertil Damato, MD, PhD

Bertil Damato, MD, PhD

Professor of Clinical Ophthalmology, UCSF

Cancer Center Program Memberships


Research Summary

Dr. Bertil Eric Damato, MD, PhD, is Professor of Ophthalmology and Radiation Oncology and Director of the Ocular Oncology Service at the University of California, San Francisco.

He did his undergraduate training in Malta, where he was born, and completed his post-graduate education in Glasgow. Before 2013, he was Consultant Ophthalmologist at the Royal Liverpool University Hospital, where he was Director of the Ocular Oncology Service, which he established in 1993.

Dr. Damato has published more than 200 peer-reviewed articles, 68 reviews, 75 book chapters and 6 books, one as single author.

He has served as Founding Secretary then President of the European Ophthalmic Oncology Group; President of the European Vision and Eye Research Association; and Vice-President then President of the International Society of Ocular Oncology.


Medical School, University of Malta MD, 1972-1977, Medicine
Glasgow Royal Infirmary, Scotland, 1978-1979, Resident Surgery & Medicine
Glasgow Royal Infirmary, Scotland, 1979-198,0 Sen.House Officer,  Pathology
Western Infirmary/ University of Glasgow, Scotland, FRCS; PhD; FRCOphth, 1980-1987, Registrar/Sen.Registrar/, Lecturer (Fellow), Ophthalmology

Professional Experience

  • 1987-1991
    Senior Lecturer, Ophthalmology, University of Glasgow, Scotland.
  • 1992-1996
    Hon. Secretary, Founding Committee, European Ophthalmic Oncology Group (OOG).
  • 1991-1992
    Reader, Ophthalmology, University of Glasgow, Scotland.
  • 1993-2013
    Consultant (i.e., Attending), Ophthalmology, Royal Liverpool University Hospital, UK.
  • 1997-1999
    President, European Ophthalmic Oncology Group, Program Director/Principal Investigator
  • 2000-present
    Hon. Professor, University of Liverpool, England.
  • 2000-2001
    President, European Vision and Eye Research (EVER).
  • 2007-2011
    Vice-President, International Society of Ocular Oncology (ISOO).
  • 2011-2013
    President, International Society of Ocular Oncology.
  • 2012-present
    Chair, Program Committee, American Association of Ocular Oncologists and Pathologists.
  • 2013-present
    Hon. Consultant, Ophthalmology, Royal Liverpool University Hospital, UK.
  • 2013-present
    Professor, Ophthalmology and Radiation Oncology, University of California, San Francisco.

Honors & Awards

  • 1970
    Old Edwardian Medal for Best All Rounder, St. Edward’s College, Malta
  • 1973
    Professor Pace Prize for Research in Anatomy, University of Malta
  • 1977
    Begley Prize, Royal College of Surgeons, England
  • 1983
    Mary Hawthorne Prize for Research, University of Glasgow, Scotland
  • 1994
    Honorary Fellow, Ophthalmological Society of Alberta
  • 2004
    Innovation Award (Highly Commended), National Health Service North West, England
  • 2004
    Hospital Doctor of the Year (Finalist), Hospital Doctor, England
  • 2006
    Lifetime Achievement Award, International Conference on Adjuvant Therapy of Malignant Melanoma, Sweden
  • 2006
    Bjerrum Medal, Danish Ophthalmological Society, Denmark
  • 2008
    Sam and Dora Cohen Gold Medal, University of the Witwatersrand, South Africa
  • 2009
    Platinum Award, Advisory Committee on Clinical Excellence Awards, National Health Service, England
  • 2010
    Honorary Fellowship, College of Optometrists, England
  • 2011
    Innovation Award (Commended), Royal College of Ophthalmologists, United Kingdom
  • 2011
    Team of the Year (Commended), Pfizer Excellence in Oncology Awards
  • 2012
    Ashton Medal, Royal College of ophthalmologists, United Kingdom
  • 2012
    Watson Medal, Cambridge Ophthalmological Symposium
  • 2012
    Jerry Shields Award, Asia-Pacific Society of Ocular Oncology and Pathology, Hong Kong
  • 2013
    Paul Harris Fellowship, Rotary Club of Mid Wirral

Selected Publications

  1. Brown SL, Hope-Stone L, Heimann H, Damato B, Salmon P. Predictors of anxiety and depression two years following treatment in uveal melanoma survivors. Psychooncology. 2018 Mar 30.
    View on PubMed
  2. Damato B. Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - A personal view. Prog Retin Eye Res. 2018 Mar 20.
    View on PubMed
  3. Damato B, Hope-Stone L, Cooper B, Brown S, Salmon P, Heimann H, Dunn L. Patient-Reported Outcomes and Quality of Life after Treatment of Choroidal Melanoma: a Comparison of Enucleation vs Radiotherapy in 1596 patients. Am J Ophthalmol. 2018 Mar 16.
    View on PubMed
    View on PubMed
  5. Ho VWM, Hussain RN, Czanner G, Sen J, Heimann H, Damato BE. Porous Versus Nonporous Orbital Implants After Enucleation for Uveal Melanoma: A Randomized Study. Ophthal Plast Reconstr Surg. 2017 Nov/Dec; 33(6):452-458.
    View on PubMed
  6. Jmor F, Hussain RN, Damato BE, Heimann H. Photodynamic therapy as initial treatment for small choroidal melanomas. Photodiagnosis Photodyn Ther. 2017 Dec; 20:175-181.
    View on PubMed
  7. Rospond-Kubiak I, Kociecki J, Damato B. Clinical evaluation of a paper chart for predicting ruthenium plaque placement in relation to choroidal melanoma. Eye (Lond). 2018 Feb; 32(2):421-425.
    View on PubMed
  8. Mustafi D, Damato B, Berry JL. Unilateral Multifocal Choroidal Melanoma. Ocul Oncol Pathol. 2017 Dec; 4(1):48-51.
    View on PubMed
  9. Coupland SE, Taktak A, Damato B. Incorporating Clinical, Histological, and Genetic Parameters for Choroidal Melanoma Prognostication. JAMA Ophthalmol. 2017 Jul 01; 135(7):818-819.
    View on PubMed
  10. Angi M, Kalirai H, Taktak A, Hussain R, Groenewald C, Damato BE, Heimann H, Coupland SE. Prognostic biopsy of choroidal melanoma: an optimised surgical and laboratory approach. Br J Ophthalmol. 2017 08; 101(8):1143-1146.
    View on PubMed
  11. Olsen AS, Steensberg AT, la Cour M, Kjaer TW, Damato B, Pinborg LH, Kolko M. Can DMCO Detect Visual Field Loss in Neurological Patients? A Secondary Validation Study. Ophthalmic Res. 2017; 58(2):85-93.
    View on PubMed
  12. Wang VE, Young L, Ali S, Miller VA, Urisman A, Wolfe J, Bivona TG, Damato B, Fogh S, Bergsland EK. A Case of Metastatic Atypical Neuroendocrine Tumor with ALK Translocation and Diffuse Brain Metastases. Oncologist. 2017 Jul; 22(7):768-773.
    View on PubMed
  13. Dogrusöz M, Jager MJ, Damato B. Corrigendum : Uveal Melanoma Treatment and Prognostication. Asia Pac J Ophthalmol (Phila). 2017 May-Jun; 6(3):305.
    View on PubMed
  14. Dogrusöz M, Jager MJ, Damato B. Uveal Melanoma Treatment and Prognostication. Asia Pac J Ophthalmol (Phila). 2017 Mar-Apr; 6(2):186-196.
    View on PubMed
  15. Konstantinidis L, Damato B. Intraocular Metastases--A Review. Asia Pac J Ophthalmol (Phila). 2017 Mar-Apr; 6(2):208-214.
    View on PubMed
  16. DeParis SW, Taktak A, Eleuteri A, Enanoria W, Heimann H, Coupland SE, Damato B. External Validation of the Liverpool Uveal Melanoma Prognosticator Online. Invest Ophthalmol Vis Sci. 2016 Nov 01; 57(14):6116-6122.
    View on PubMed
  17. Vallabh NA, Sahni JN, Parkes CK, Czanner G, Heimann H, Damato B. Near-infrared reflectance and autofluorescence imaging characteristics of choroidal nevi. Eye (Lond). 2016 Dec; 30(12):1593-1597.
    View on PubMed
  18. Hope-Stone L, Brown SL, Heimann H, Damato B, Salmon P. Two-year patient-reported outcomes following treatment of uveal melanoma. Eye (Lond). 2016 Dec; 30(12):1598-1605.
    View on PubMed
  19. Hussain RN, Jmor F, Damato B, Heimann H. Verteporfin photodynamic therapy for the treatment of choroidal haemangioma associated with Sturge-Weber syndrome. Photodiagnosis Photodyn Ther. 2016 Sep; 15:143-6.
    View on PubMed
  20. Hussain RN, Kalirai H, Groenewald C, Kacperek A, Errington RD, Coupland SE, Heimann H, Damato B. Prognostic Biopsy of Choroidal Melanoma after Proton Beam Radiation Therapy. Ophthalmology. 2016 10; 123(10):2264-5.
    View on PubMed

Go to UCSF Profiles, powered by CTSI